Discover how DNA methylation and AI can now predict your risk for chronic diseases like cancer, heart disease, and Alzheimer’s from a single drop of blood.
Uncover how epigenetic clocks and biomarker proxies are replacing outdated diagnostic tools and enabling more precise, personalized longevity interventions.
Understand how therapeutic response can now be predicted using biological age data, helping clinicians guide patients toward the most effective treatments.
Richard Handley is a Harvard-trained physician executive, longevity expert, and U.S. Navy veteran with over 20 years of clinical experience as a PA. He has served in primary care, emergency medicine, and occupational health, earning...
Ryan Smith attended Transylvania University and graduated with a degree in Biochemistry. In that time, he had multiple research internships at the University of Kentucky and the University of Pennsylvania studying large scale...